Dopamine across timescales and cell types: Relevance for phenotypes in Parkinson's disease progression

被引:0
|
作者
Seiler, Jillian L. [1 ,7 ]
Zhuang, Xiaowen [3 ,5 ,6 ,7 ]
Nelson, Alexandra B. [3 ,4 ,5 ,6 ,7 ,8 ]
Lerner, Talia N. [1 ,2 ,7 ,9 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Neurosci, Chicago, IL USA
[2] Northwestern Univ Interdept Neurosci Program NUIN, Evanston, IL USA
[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
[4] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA USA
[5] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA USA
[6] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA USA
[7] Aligning Sci Parkinsons ASAP Collaborat Res Networ, Chevy Chase, MD USA
[8] UCSF, MC 0663,675 Nelson Rising Lane, San Francisco, CA 94158 USA
[9] Ward 5 120, 303 Chicago Ave, Chicago, IL 60611 USA
关键词
Parkinson's disease; Movement disorders; Neurodegeneration; L-DOPA; Dopamine; Substantia nigra pars compacta; Striatum; Cell types; Heterogeneity; AMINO-ACID DECARBOXYLASE; SUBSTANTIA-NIGRA; EXTRACELLULAR DOPAMINE; NEURONAL VULNERABILITY; INDUCED DYSKINESIA; NMDA-RECEPTORS; 6-OHDA LESIONS; STRIATUM; BRAIN; PLASTICITY;
D O I
10.1016/j.expneurol.2024.114693
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dopamine neurons in the substantia nigra pars compacta (SNc) synthesize and release dopamine, a critical neurotransmitter for movement and learning. SNc dopamine neurons degenerate in Parkinson's Disease (PD), causing a host of motor and non-motor symptoms. Here, we review recent conceptual advances in our basic understanding of the dopamine system - including our rapidly advancing knowledge of dopamine neuron heterogeneity - with special attention to their importance for understanding PD. In PD patients, dopamine neuron degeneration progresses from lateral SNc to medial SNc, suggesting clinically relevant heterogeneity in dopamine neurons. With technical advances in dopamine system interrogation, we can understand the relevance of this heterogeneity for PD progression and harness it to develop new treatments.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Imaging of dopamine transporters: Biomarker for progression in Parkinson's disease
    Innis, RB
    Seibyl, J
    Marek, K
    CNS DRUG REVIEWS, 2000, 6 : 33 - 33
  • [2] Disease progression and phenotypes of non-motor symptoms in Parkinson's disease
    Osaki, Yasushi
    Morita, Yukari
    Miyamoto, Yuka
    Furushima, Tomomi
    Furuta, Konosuke
    Furuya, Hirokazu
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2021, 9 (01): : 83 - 90
  • [3] VIP protects from dopamine toxicity: relevance for Parkinson's disease
    Offen, D
    Melamed, E
    Fridkin, M
    Brenneman, DE
    Gozes, I
    BRAIN RESEARCH, 1999, 848 (1-2) : A36 - A36
  • [4] Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: Relevance to Parkinson's disease
    Zhang, J
    Kravtsov, V
    Amarnath, V
    Picklo, MJ
    Graham, DG
    Montine, TJ
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 (03) : 970 - 978
  • [5] Effects of the capacity of dopamine sequestration on the rate of progression in Parkinson's disease
    Qasem, A
    Schulzer, M
    Sossi, V
    Ruth, TJ
    Calne, DB
    Stoessl, AJ
    Lee, CS
    NEUROLOGY, 2005, 64 (06) : A274 - A275
  • [6] Do dopamine agonists or levodopa modify Parkinson's disease progression?
    Marek, K
    Jennings, D
    Seibyl, J
    EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 : 15 - 22
  • [7] Slowing Parkinson's disease progression - Recent dopamine agonist trials
    Ahlskog, JE
    NEUROLOGY, 2003, 60 (03) : 381 - 389
  • [8] Dopamine-Angiotensin Interactions in the Basal Ganglia and Their Relevance for Parkinson's Disease
    Labandeira-Garcia, Jose L.
    Rodriguez-Pallares, Jannette
    Dominguez-Meijide, Antonio
    Valenzuela, Rita
    Villar-Cheda, Begona
    Rodriguez-Perez, Ana I.
    MOVEMENT DISORDERS, 2013, 28 (10) : 1337 - 1342
  • [9] Editorial: Parkinson's disease: cell vulnerability and disease progression
    Blesa, Javier
    Lanciego, Jose L.
    Obeso, Jose A.
    FRONTIERS IN NEUROANATOMY, 2015, 9
  • [10] Nigral iron deposition occurs across motor phenotypes of Parkinson's disease
    Jin, L.
    Wang, J.
    Jin, H.
    Fei, G.
    Zhang, Y.
    Chen, W.
    Zhao, L.
    Zhao, N.
    Sun, X.
    Zeng, M.
    Zhong, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (07) : 969 - 976